Abstract
Aim:
The substantia nigra pars reticulata (SNr) constitutes one of the output centers of the basal ganglia, and its abnormal activity is believed to contribute to some basal ganglia motor disorders. Different lines of evidence revealed a major contribution of GABAA receptor-mediated synaptic inhibition in controlling the activity of SNr. The benzodiazepine binding site within the GABAA receptor is a modulation site of significant clinical interest. A high density of benzodiazepine binding sites has been reported in the rat SNr. In the present study, we investigate the effects of activating benzodiazepine binding sites in the SNr.
Methods:
Whole-cell patch-clamp recordings and motor behavior were applied.
Results:
Superfusion of zolpidem, a benzodiazepine binding agonist, at 100 nmol/L significantly prolonged the decay time of GABAA receptor-mediated postsynaptic currents. The prolongation on decay time induced by zolpidem was sensitive to the benzodiazepine antagonist flumazenil, confirming the specificity on the benzodiazepine site. Zolpidem at 1 μmol/L exerted a stronger prolongation on the decay time. A further experiment was performed on behaving rats. A unilateral microinjection of zolpidem into the rat SNr caused a robust contralateral rotation, which was significantly different from that of control animals receiving the vehicle injection.
Conclusion:
The present in vitro and in vivo findings that zolpidem significantly potentiated GABA currents and thus inhibited the activity of the SNr provide a rationale for further investigations into its potential in the treatment of basal ganglia disorders.
Similar content being viewed by others
Article PDF
References
Ottersen OP, Storm-Mathisen J . Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J Comp Neurol 1984; 229: 374–92.
Smith Y, Bolam JP . The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J Comp Neurol 1990; 296: 47–64.
Nitsch C, Riesenberg R . Immunocytochemical demonstration of GABAergic synaptic connections in rat substantia nigra after different lesions of the striatonigral projection. Brain Res 1988; 461: 127–42.
Lantin le Boulch N, Truong-Ngoc NA, Gauchy C, Besson MJ . In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallidonigral afferents and nigral GABA neurons. Brain Res 1991; 559: 200–10.
Somogyi P, Bolam J P, Smith AD . Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-degeneration procedure. J Comp Neurol 1981; 195: 567–84.
Nicholson LF, Faull RL, Waldvogel HJ, Dragunow M . The regional, cellular and subcellular localization of GABAA/benzodiazepine receptors in the substantia nigra of the rat. Neuroscience 1992; 50: 355–70.
Wisden W, Laurie DJ, Monyer H, Seeburg PH . The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040–62.
Mehta, AK, Ticku MK . An update on GABAA receptors. Brain Res Brain Res Rev 1999; 29: 196–217.
Niddam R, Dubois A, Scatton B, Arbilla S, Langer SZ . Autoradio-graphic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites. J Neurochem 1987; 49: 890–9.
Chadha A, Dawson LG, Jenner PG, Duty S . Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA (A) receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience 2000; 95: 119–26.
Pan HS, Penney JB, Young AB . Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 1985; 45: 1396–404.
Mereu G, Carcangiu G, Concas A, Passino N, Biggio G . Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors. Eur J Pharmacol 1990; 179: 339–45.
Veliskova J, Loscher W, Moshe SL . Regional and age specific effects of zolpidem microinfusions in the substantia nigra on seizures. Epilepsy Res 1998; 30: 107–14.
Zhang H, Rosenberg HC, Tietz EI . Anticonvulsant actions and interaction of GABA agonists and a benzodiazepine in pars reticulata of substantia nigra. Epilepsy Res 1991; 8: 11–20.
Daniele A, Albanese A, Gainotti G, Gregori B, Bartolomeo P . Zolpidem in Parkinson's disease. Lancet 1997; 349: 1222–3.
Ruzicka E, Roth J, Jech R, Busek P . Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease. Mov Disord 2000; 15: 734–5.
Farver DK, Khan MH . Zolpidem for antipsychotic-induced parkinsonism. Ann Pharmacother 2001; 35: 435–7.
Chan PK, Yung WH . Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake. Brain Res 1999; 838: 18–26.
Yung WH, Hausser MA, Jack JJ . Electrophysiology of dopamin-ergic and non-dopaminergic neurones of the guinea-pig substan-tia nigra pars compacta in vitro. J Physiol 1991; 436: 643–67.
Hausser MA, Yung WH . Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. J Physiol 1994; 479: 401–22.
Costa E . From GABAA receptor diversity emerges a unified vision of GABAergic inhibition. Annu Rev Pharmacol Toxicol 1998; 38: 321–50.
Rudolph U, Crestani F, Mohler H . GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 2001; 22: 188–94.
Sieghart W . Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 1995; 47: 181–234.
Duncan GE, Breese GR, Criswell HE, McCown TJ, Herbert JS, Devaud LL, et al. Distribution of [3H]zolpidem binding sites in relation to messenger RNA encoding the alpha 1, beta 2 and gamma 2 subunits of GABAA receptors in rat brain. Neuroscience 1995; 64: 1113–28.
Macdonald RL, Olsen RW . GABAA receptor channels. Annu Rev Neurosci 1994; 17: 569–602.
Perrais D, Ropert N . Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J Neurosci 1999; 19: 578–88.
Criswell HE, McCown TJ, Moy SS, Oxford GS, Mueller RA, Morrow AL, et al. Action of zolpidem on responses to GABA in relation to mRNAs for GABA(A) receptor alpha subunits within single cells: evidence for multiple functional GABA(A) isoreceptors on individual neurons. Neuropharmacology 1997; 36: 1641–52.
Vicini S, Ferguson C, Prybylowski K, Kralic J, Morrow AL, Homanics GE . GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 2001; 21: 3009–16.
Deransart C, Hellwig B, Heupel-Reuter M, Leger JF, Heck D, Lucking CH . Single-unit analysis of substantia nigra pars reticulata neurons in freely behaving rats with genetic absence epilepsy. Epilepsia 2003; 44: 1513–20.
Bloms-Funke P, Loscher W . The anticonvulsant gabapentin decreases firing rates of substantia nigra pars reticulata neurons. Eur J Pharmacol 1996; 316: 211–8.
Shi LH, Luo F, Woodward D, Chang JY . Deep brain stimulation of the substantia nigra pars reticulata exerts long lasting suppression of amygdala-kindled seizures. Brain Res 2006; 1090: 202–7.
Olsen RW, Wamsley JK, McCabe RT, Lee RJ, Lomax P . Benzodiazepine/γ-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil. Proc Natl Acad Sci USA 1985; 82: 6701–5.
Kumar SS, Wen X, Yang Y, Buckmaster PS . GABAA receptor-mediated IPSCs and alpha 1 subunit expression are not reduced in the substantia nigra pars reticulate of gerbils with inherited epilepsy. J Neurophysiol 2006; 95: 2446–55.
Shehab S, Simkins M, Dean P, Redgrave P . Regional distribution of the anticonvulsant and behavioural effects of muscimol injected into the substantia nigra of rats. Eur J Neurosci 1996; 8: 749–57.
Veliskova J, Velisek L, Nunes ML, Moshe SL . Developmental regulation of regional functionality of substantial nigra GABAA receptors involved in seizures. Eur J Pharmacol 1996; 309: 167–73.
Loscher W, Ebert U, Lehmann H, Rosenthal C, Nikkhah G . Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. J Neurosci Res 1998; 51: 196–209.
Gonzalez Ramirez M, Orozco Suarez S, Salgado Ceballos H, Feria Velasco A, Rocha L . Hyperthermia-induced seizures modify the GABA(A) and benzodiazepine receptor binding in immature rat crain. Cell Mol Neurobiol 2007; 27: 211–27.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Research Grants Council of Hong Kong (No CUHK 4175/02M to Dr Wing-ho Yung) and the Foundation of Health Department of Shandong Province (No 2005HW021 to Dr Lei Chen).
Rights and permissions
About this article
Cite this article
Zhang, Ll., Chen, L., Xue, Y. et al. Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata . Acta Pharmacol Sin 29, 161–168 (2008). https://doi.org/10.1111/j.1745-7254.2008.00735.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00735.x
Keywords
This article is cited by
-
Effects of Stimulation of the Substantia Innominata and Caudate Nucleus on Postsynaptic Reactions of Neurons of the Cat Somatosensory Cortex Activated by Excitation of Nociceptors
Neurophysiology (2014)
-
Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABAA receptors in vitro
Acta Pharmacologica Sinica (2012)
-
After-hyperpolarization currents and acetylcholine control sigmoid transfer functions in a spiking cortical model
Journal of Computational Neuroscience (2012)